Global initiative for chronic obstructive lung disease.

[1]  N. Anthonisen,et al.  Alteration in breathing pattern with progression of chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[2]  J. Hogg,et al.  Morphology of peripheral airways in current smokers and ex-smokers. , 2015, The American review of respiratory disease.

[3]  K. Nugent,et al.  Bronchodilator testing: confidence intervals derived from placebo inhalations. , 2015, The American review of respiratory disease.

[4]  T. Petty,et al.  Small airway pathology is related to increased closing capacity and abnormal slope of phase III in excised human lungs. , 2015, The American review of respiratory disease.

[5]  R. Wood‐Baker,et al.  Influenza vaccine for patients with chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.

[6]  A. Crockett,et al.  Domiciliary oxygen for chronic obstructive pulmonary disease. , 2005, The Cochrane database of systematic reviews.

[7]  W. Dejsomritrutai,et al.  Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. , 2004, Chest.

[8]  B. Grant,et al.  Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[9]  J. Wedzicha,et al.  Sleep disordered breathing awoken , 2003, Thorax.

[10]  P. Calverley,et al.  Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.

[11]  D. Johns,et al.  Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease , 2003, Internal medicine journal.

[12]  H Putter,et al.  Correlation between annual change in health status and computer tomography derived lung density in subjects with α1-antitrypsin deficiency , 2003, Thorax.

[13]  Margareta Emtner,et al.  Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. , 2003, American journal of respiratory and critical care medicine.

[14]  E. R. Sutherland,et al.  Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. , 2003, The Journal of allergy and clinical immunology.

[15]  J. van der Palen,et al.  Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[16]  R. Atmar,et al.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[17]  I. Pavord,et al.  Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[18]  P. Young,et al.  Shortburst oxygen immediately before and after exercise is ineffective in nonhypoxic COPD patients , 2003, European Respiratory Journal.

[19]  R. Pauwels,et al.  Chronic obstructive pulmonary disease: molecular and cellularmechanisms , 2003, European Respiratory Journal.

[20]  N. Chavannes,et al.  Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) , 2003, Thorax.

[21]  R. Hubbard,et al.  Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey , 2003, BMJ : British Medical Journal.

[22]  B. Rowe,et al.  Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials , 2003, BMJ : British Medical Journal.

[23]  L. Trupin,et al.  The occupational burden of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[24]  N. Hanania,et al.  The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD , 2003 .

[25]  R. Zuwallack,et al.  An evaluation of nebulized levalbuterol in stable COPD. , 2003, Chest.

[26]  M. Steiner,et al.  Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial , 2003, Thorax.

[27]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[28]  Pma Calverley,et al.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.

[29]  R. Stockley,et al.  Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis , 2003, Thorax.

[30]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[31]  I. Stiell,et al.  Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. , 2003, The New England journal of medicine.

[32]  D. Mannino,et al.  Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. , 2003, The American journal of medicine.

[33]  K. N. Maranetra,et al.  Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[34]  P. Jones,et al.  Methodological issues in evaluating measures of health as outcomes for COPD , 2003, European Respiratory Journal.

[35]  J. Wedzicha,et al.  COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.

[36]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[37]  Onchee Yu,et al.  Effectiveness of pneumococcal polysaccharide vaccine in older adults. , 2003, The New England journal of medicine.

[38]  V. Peinado,et al.  Pulmonary hypertension in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[39]  G. Guyatt,et al.  Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease , 2003, Thorax.

[40]  Martin J Connolly,et al.  Early mobilization with walking aids following hospital admission with acute exacerbation of chronic obstructive pulmonary disease , 2003, Clinical rehabilitation.

[41]  B. Rowe,et al.  Methylxanthines for exacerbations of chronic obstructive pulmonary disease. , 2003, The Cochrane database of systematic reviews.

[42]  D. Postma,et al.  Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. , 2003, Thorax.

[43]  G. Downey,et al.  Proteases and lung injury , 2003, Critical care medicine.

[44]  Abdissa Negassa,et al.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[45]  R. Kaplan,et al.  Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. , 2003, American journal of respiratory and critical care medicine.

[46]  F. Maltais,et al.  Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. , 2003, Archives of internal medicine.

[47]  E. Wouters.  The burden of COPD in The Netherlands: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[48]  L. Fabbri,et al.  Predominant emphysema phenotype in chronic obstructive pulmonary disease patients , 2003, European Respiratory Journal.

[49]  R. Buhl,et al.  Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD. , 2003, Chest.

[50]  E. Wouters.  Economic analysis of the Confronting COPD survey: an overview of results. , 2003, Respiratory medicine.

[51]  Kathleen Kreiss,et al.  American Thoracic Society Statement: Occupational contribution to the burden of airway disease. , 2003, American journal of respiratory and critical care medicine.

[52]  M. Tsukino,et al.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.

[53]  유상준,et al.  Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[54]  J. Wedzicha,et al.  Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[55]  P. Jones,et al.  Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations , 2003, European Respiratory Journal.

[56]  J. Alonso,et al.  Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients , 2003, European Respiratory Journal.

[57]  Andrew J. White,et al.  Chronic obstructive pulmonary disease • 6: The aetiology of exacerbations of chronic obstructive pulmonary disease , 2003, Thorax.

[58]  R. Sansores,et al.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[59]  S. Borg,et al.  Costs of COPD in Sweden according to disease severity. , 2002, Chest.

[60]  P. Tarsia,et al.  Duplicate publication , 2002, Thorax.

[61]  J. van der Palen,et al.  Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. , 2002, American journal of respiratory and critical care medicine.

[62]  A. Buist,et al.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.

[63]  J. Higgins,et al.  A systematic review of the use of opioids in the management of dyspnoea , 2002, Thorax.

[64]  D Olivieri,et al.  Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial). , 2002, Respiratory medicine.

[65]  P. Jones,et al.  Oral theophylline for chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.

[66]  Surinder S Birring,et al.  Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. , 2002, American journal of respiratory and critical care medicine.

[67]  Ki Moon Bang,et al.  Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. , 2002, American journal of epidemiology.

[68]  J. Yates,et al.  Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[69]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[70]  A. Corrado,et al.  The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients , 2002, European Respiratory Journal.

[71]  M. Elliott.  Noninvasive ventilation in chronic ventilatory failure due to chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[72]  G. Kwakkel,et al.  Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis , 2002, European Respiratory Journal.

[73]  John E Connett,et al.  Smoking and lung function of Lung Health Study participants after 11 years. , 2002, American journal of respiratory and critical care medicine.

[74]  M. Antonelli,et al.  Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial , 2002, Intensive Care Medicine.

[75]  B. Grant,et al.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.

[76]  X. Busquets,et al.  Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[77]  W. S. Ring,et al.  Consensus Conference Report , 2002 .

[78]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[79]  P. Young,et al.  Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study , 2002, European Respiratory Journal.

[80]  F. Blasi,et al.  Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment , 2002, Thorax.

[81]  N. Anthonisen,et al.  Hospitalizations and mortality in the Lung Health Study. , 2002, American journal of respiratory and critical care medicine.

[82]  Shin-Ping Tu,et al.  Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. , 2002, Chest.

[83]  A. Buist.  Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[84]  S. Yeh,et al.  Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. , 2002, Chest.

[85]  M. Greenstone,et al.  Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.

[86]  I. Pavord,et al.  Clinical applications of assessment of airway inflammation using induced sputum , 2002, European Respiratory Journal.

[87]  I. Vogiatzis,et al.  Interval training as an alternative modality to continuous exercise in patients with COPD , 2002, European Respiratory Journal.

[88]  O. Johnell,et al.  Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler® , 2002, European Respiratory Journal.

[89]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[90]  V. García,et al.  Hospitalización a domicilio , 2002 .

[91]  A. Schols,et al.  Systemic effects in COPD. , 2002, Chest.

[92]  R. Stockley.  Neutrophils and the pathogenesis of COPD. , 2002, Chest.

[93]  Ramon Gisbert,et al.  Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. , 2002, Chest.

[94]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[95]  J. Wedzicha.  Exacerbations , 2002, Chest.

[96]  Edwin K Silverman,et al.  Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. , 2002, American journal of human genetics.

[97]  M. Cosio,et al.  Inflammation of the airways and lung parenchyma in COPD: role of T cells. , 2002, Chest.

[98]  R. Taylor,et al.  NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE) , 2002, International Journal of Technology Assessment in Health Care.

[99]  G. Della Cioppa,et al.  Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. , 2002, Chest.

[100]  R. Casaburi,et al.  Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. , 2002, Chest.

[101]  Jerome J. Schentag,et al.  A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. , 2002, Clinical therapeutics.

[102]  A. Diacon,et al.  Functional evaluation before lung resection. , 2002, Clinics in chest medicine.

[103]  F. Maltais,et al.  Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. , 2002, American journal of respiratory and critical care medicine.

[104]  A. Morice,et al.  Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial , 2002, Thorax.

[105]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[106]  J. V. van Noord,et al.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.

[107]  R. Casaburi,et al.  Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. , 2002, Chest.

[108]  A. Anzueto,et al.  Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. , 2002, JAMA.

[109]  T. Churches,et al.  Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study , 2002, Thorax.

[110]  F. Abroug,et al.  Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial , 2001, The Lancet.

[111]  P. Jones,et al.  Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.

[112]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[113]  W. MacNee,et al.  Oxidative stress and lung inflammation in airways disease. , 2001, European journal of pharmacology.

[114]  N J Wareham,et al.  Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. , 2001, American journal of respiratory and critical care medicine.

[115]  K. Norris,et al.  The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. , 2001, The New Zealand medical journal.

[116]  Steven Piantadosi,et al.  Patients at high risk of death after lung-volume-reduction surgery. , 2001, The New England journal of medicine.

[117]  M. Burr,et al.  Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme , 2001, Thorax.

[118]  R. Dahl,et al.  Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[119]  M. Elliott,et al.  Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.

[120]  D. O’Donnell,et al.  Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[121]  S. Lareau,et al.  Memory for symptoms in COPD patients: how accurate are their reports? , 2001, The European respiratory journal.

[122]  L Battolla,et al.  Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[123]  N. Anthonisen,et al.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.

[124]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[125]  S. M. Lee,et al.  Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. , 2001, The European respiratory journal.

[126]  B. Dautzenberg,et al.  European Respiratory Society Guidelines on the use of nebulizers. , 2001, The European respiratory journal.

[127]  R. Zuwallack,et al.  Salmeterol plus theophylline combination therapy in the treatment of COPD. , 2001, Chest.

[128]  J. Finnerty,et al.  The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. , 2001, Chest.

[129]  P. Anderson,et al.  Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.

[130]  E. Bozkanat,et al.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease , 2001, Respiratory research.

[131]  L. Fabbri,et al.  Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[132]  D. Mccrory,et al.  Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence , 2001, Annals of Internal Medicine.

[133]  I. Weisman.  Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery. , 2001, Seminars in thoracic and cardiovascular surgery.

[134]  S. Hurd,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[135]  D. O’Donnell,et al.  Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[136]  R. Stockley,et al.  Exercise capacity predicts health status in α1-Antitrypsin deficiency , 2001 .

[137]  S. Sullivan,et al.  The costs of treating COPD in the United States. , 2001, Chest.

[138]  Sally J. Singh,et al.  A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease , 2001, Thorax.

[139]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[140]  J. Connett,et al.  Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[141]  A. Giobbie-Hurder,et al.  Effectiveness of team-managed home-based primary care: a randomized multicenter trial. , 2000, JAMA.

[142]  D. Niewoehner,et al.  Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial. , 2000, American journal of respiratory and critical care medicine.

[143]  E. Silverman,et al.  Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[144]  H. Magnussen,et al.  Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[145]  B. Grant,et al.  Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.

[146]  R M Angus,et al.  “Hospital at home” versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial , 2000, BMJ : British Medical Journal.

[147]  C. Bucknall,et al.  Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial , 2000, Thorax.

[148]  W. MacNee,et al.  Randomised controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease , 2000 .

[149]  Kirk R. Smith,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:National burden of disease in India from indoor air pollution , 2000 .

[150]  Jilly F. Evans,et al.  Characterization of the Human Cysteinyl Leukotriene 2 Receptor* , 2000, The Journal of Biological Chemistry.

[151]  N Künzli,et al.  Public-health impact of outdoor and traffic-related air pollution: a European assessment , 2000, The Lancet.

[152]  R. Crapo,et al.  FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. , 2000, American journal of respiratory and critical care medicine.

[153]  N. Lazzeri,et al.  Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. , 2000, American journal of respiratory and critical care medicine.

[154]  R. Zuwallack,et al.  Functional status and survival following pulmonary rehabilitation. , 2000, Chest.

[155]  N. Pride,et al.  Recent trends in physician diagnosed COPD in women and men in the UK , 2000, Thorax.

[156]  L. Stead,et al.  Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library , 2000, BMJ : British Medical Journal.

[157]  R. Stockley,et al.  Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care , 2000, Thorax.

[158]  D. Hansell,et al.  Effect of lung-volume-reduction surgery in patients with severe emphysema. , 2000, The New England journal of medicine.

[159]  L. M. Barnett.  The Evolution of British General Practice, 1850-1948 , 2000 .

[160]  P. Plant,et al.  Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial , 2000, The Lancet.

[161]  R. Stockley,et al.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.

[162]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[163]  R. Rodríguez-Roisín,et al.  Toward a consensus definition for COPD exacerbations. , 2000, Chest.

[164]  M J Tobin,et al.  How is mechanical ventilation employed in the intensive care unit? An international utilization review. , 2000, American journal of respiratory and critical care medicine.

[165]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[166]  W. Hop,et al.  Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.

[167]  J. V. van Noord,et al.  A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease , 2000 .

[168]  C F Donner,et al.  Physiologic determinants of ventilator dependence in long-term mechanically ventilated patients. , 2000, American journal of respiratory and critical care medicine.

[169]  C. C. Christensen,et al.  Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. , 2000, The European respiratory journal.

[170]  A. Buist,et al.  Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. , 2000, Chest.

[171]  H. Nagaraja,et al.  Increased Susceptibility to Pulmonary Emphysema among HIV-Seropositive Smokers , 2000, Annals of Internal Medicine.

[172]  A R Jadad,et al.  Systematic reviews and meta-analyses on treatment of asthma: critical evaluation , 2000, BMJ : British Medical Journal.

[173]  N. Payne,et al.  Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.

[174]  J. Vestbo,et al.  Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[175]  N. Zamel,et al.  Lung function 4 years after lung volume reduction surgery for emphysema. , 1999, Chest.

[176]  R. Davies,et al.  Airway epithelial cells, cytokines, and pollutants. , 1999, American journal of respiratory and critical care medicine.

[177]  S. Rennard.  Inflammation and repair processes in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[178]  J C Jager,et al.  Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. , 1999, Respiratory medicine.

[179]  J. Vestbo,et al.  Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. , 1999, Respiratory medicine.

[180]  N. Adair,et al.  Exercise rehabilitation and chronic obstructive pulmonary disease stage. , 1999, American journal of respiratory and critical care medicine.

[181]  N. Gross,et al.  Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium. , 1999, American journal of respiratory and critical care medicine.

[182]  R. Stockley,et al.  The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. , 1999, American journal of respiratory and critical care medicine.

[183]  T. Murphy,et al.  Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. , 1999, The Journal of infectious diseases.

[184]  D. O’Donnell,et al.  Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[185]  T. Eaton,et al.  Clinical InvestigationsMiscellaneousSpirometry in Primary Care Practice: The Importance of Quality Assurance and the Impact of Spirometry Workshops , 1999 .

[186]  J. Macmahon,et al.  Cost minimisation analysis of provision of oxygen at home: are the Drug Tariff guidelines cost effective? , 1999, BMJ.

[187]  M. Miravitlles,et al.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. , 1999, Chest.

[188]  D. Spandidos,et al.  Microsatellite DNA instability in COPD. , 1999, Chest.

[189]  B. Isalska,et al.  Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. , 1999, American journal of respiratory and critical care medicine.

[190]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[191]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[192]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[193]  K. Hirata,et al.  Plasma Endothelin-1 Level in Chronic Obstructive Pulmonary Disease: Relationship with Natriuretic Peptide , 1999, Respiration.

[194]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[195]  T. Braciale,et al.  Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. , 1999, American journal of respiratory cell and molecular biology.

[196]  V. Peinado,et al.  Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[197]  J. Vestbo,et al.  Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. , 1999, The European respiratory journal.

[198]  P. Tousignant,et al.  The health and cost effects of substituting home care for inpatient acute care: a review of the evidence. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[199]  A. Buist,et al.  Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. , 1999, The American journal of medicine.

[200]  S. Yancey,et al.  Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.

[201]  A. Dirksen,et al.  Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[202]  R. Pauwels,et al.  The cellular composition of induced sputum in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[203]  J. Nadel,et al.  Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. , 1999, American journal of respiratory cell and molecular biology.

[204]  G. Smetana.  Preoperative pulmonary evaluation. , 1999, The New England journal of medicine.

[205]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[206]  F. Maltais,et al.  Aerobic and strength training in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[207]  D. Mannino,et al.  Worldwide epidemiology of chronic obstructive pulmonary disease. , 1999, Current opinion in pulmonary medicine.

[208]  S T Holgate,et al.  Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. , 1999, American journal of respiratory and critical care medicine.

[209]  P. Young,et al.  Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme. , 1999, Australian and New Zealand journal of medicine.

[210]  T. Witek,et al.  Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. , 1999, Life sciences.

[211]  M. B. Allen,et al.  Medical students’ knowledge of smoking , 1999, Thorax.

[212]  P. Hiemstra,et al.  Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease , 1998 .

[213]  Elliott Mw.  The language of breathlessness. , 1998 .

[214]  G. FitzGerald,et al.  Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. , 1998, American journal of respiratory and critical care medicine.

[215]  C. van Weel,et al.  Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. , 1998, American journal of respiratory and critical care medicine.

[216]  K. Kubo,et al.  Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity. , 1998, The American journal of pathology.

[217]  A. Gulsvik,et al.  Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway. , 1998, The European respiratory journal.

[218]  M J Connolly,et al.  The effect of walking aids on exercise capacity and oxygenation in elderly patients with chronic obstructive pulmonary disease. , 1998, Age and ageing.

[219]  R. Phillips,et al.  A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. , 1998, The American journal of medicine.

[220]  F. Hargreave,et al.  Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. , 1998, American journal of respiratory and critical care medicine.

[221]  J Vestbo,et al.  A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.

[222]  L. Fabbri,et al.  Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.

[223]  N. Ambrosino,et al.  Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation. , 1998, Respiratory medicine.

[224]  M. Drehobl,et al.  Randomized, Double-Blind Study of Ciprofloxacin and Cefuroxime Axetil for Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis , 1998 .

[225]  N. Gross,et al.  Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease , 1998, Respiration.

[226]  S. Shapiro,et al.  Matrix metalloproteinase degradation of extracellular matrix: biological consequences. , 1998, Current opinion in cell biology.

[227]  J. Stoller,et al.  Inpatient management of chronic obstructive pulmonary disease. , 1998, Respiratory care clinics of North America.

[228]  W. Morgan,et al.  Maternal smoking and infant lung function. Further evidence for an in utero effect. , 1998, American journal of respiratory and critical care medicine.

[229]  L. Boulet,et al.  Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. , 1998, Chest.

[230]  P. Jones,et al.  Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. , 1998, The European respiratory journal.

[231]  P. Enright,et al.  Long-term particulate and other air pollutants and lung function in nonsmokers. , 1998, American journal of respiratory and critical care medicine.

[232]  G. Diette,et al.  Capitation, managed care, and chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[233]  B. Beghé,et al.  Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease , 1998, Thorax.

[234]  J. Gravil,et al.  Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service , 1998, The Lancet.

[235]  I. R. McWhinney,et al.  Primary care: core values Core values in a changing world , 1998, BMJ.

[236]  P. Poole,et al.  The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[237]  D. Gruson,et al.  Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency. , 1998, The European respiratory journal.

[238]  V. Peinado,et al.  Endothelial dysfunction in pulmonary arteries of patients with mild COPD. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[239]  J. Wlodarczyk,et al.  Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital. , 1998, Journal of quality in clinical practice.

[240]  C. Sanguinetti,et al.  Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[241]  M. Niederman,et al.  Clinical Investigations: Inflammation/InfectionInfective Exacerbations of Chronic Bronchitis: Relation between Bacteriologic Etiology and Lung Function , 1998 .

[242]  G. Criner,et al.  Effect of lung volume reduction surgery on diaphragm strength. , 1998, American journal of respiratory and critical care medicine.

[243]  I. Harting,et al.  Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[244]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.

[245]  M. Prato,et al.  Noninvasive Mechanical Ventilation in the Weaning of Patients with Respiratory Failure Due to Chronic Obstructive Pulmonary Disease , 1998, Annals of Internal Medicine.

[246]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[247]  R. Wilson,et al.  The role of infection in COPD. , 1998, Chest.

[248]  J. Szidon,et al.  Lung volume reduction surgery: an analysis of hospital costs. , 1998, Chest.

[249]  T. Petty.  Supportive therapy in COPD. , 1998, Chest.

[250]  M. Roth,et al.  Airway inflammation in young marijuana and tobacco smokers. , 1998, American journal of respiratory and critical care medicine.

[251]  J. Spinelli,et al.  Vitamin D binding protein variants and the risk of COPD. , 1998, American journal of respiratory and critical care medicine.

[252]  W. Maziak,et al.  Exhaled nitric oxide in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[253]  H. Fessler,et al.  Lung volume reduction surgery and airflow limitation. , 1998, American journal of respiratory and critical care medicine.

[254]  D. Postma,et al.  The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies. , 1998, Respiratory medicine.

[255]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[256]  K. Amoli.  Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke. , 1998, The European respiratory journal.

[257]  S. R. Rutgers,et al.  Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD. , 1998, American journal of respiratory and critical care medicine.

[258]  A. Wilson,et al.  Rate of FEV1 change following lung volume reduction surgery. , 1998, Chest.

[259]  W. Stalman,et al.  Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. , 1998, Journal of epidemiology and community health.

[260]  R. Novick,et al.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.

[261]  J. Collet,et al.  Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.

[262]  N. Anthonisen.  OM-85 BV for COPD , 1997 .

[263]  P Maestrelli,et al.  Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis. , 1997, American journal of respiratory and critical care medicine.

[264]  Song-Lih Huang,et al.  Tumor Necrosis Factor- α Gene Polymorphism in Chronic Bronchitis , 1997 .

[265]  R. Casaburi,et al.  Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Guidelines , 1997 .

[266]  Alison E. Ries.  Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. , 1997, Chest.

[267]  R. Hancox,et al.  The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction. , 1997, The New Zealand medical journal.

[268]  F. Hargreave,et al.  Markers of inflammation in induced sputum in acute bronchitis caused by Chlamydia pneumoniae. , 1997, Thorax.

[269]  S. Keenan,et al.  Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. , 1997, Critical care medicine.

[270]  D. Barker,et al.  Relation of fetal growth to adult lung function in south India. , 1997, Thorax.

[271]  R. Albert,et al.  Surgical options for patients with advanced emphysema. , 1997, Clinics in chest medicine.

[272]  M. Koopmanschap,et al.  Lifetime costs of lung transplantation: estimation of incremental costs. , 1997, Health economics.

[273]  D. Harrison,et al.  Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema , 1997, The Lancet.

[274]  G. Guyatt,et al.  Economic analysis of respiratory rehabilitation. , 1997, Chest.

[275]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[276]  T. Yoneda,et al.  Airway inflammation in COPD assessed by sputum levels of interleukin-8. , 1997, Chest.

[277]  A. Jones,et al.  NO: COPD and beyond , 1997, Thorax.

[278]  D. Górecka,et al.  Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.

[279]  D. Lamb,et al.  Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer , 1997, Human & experimental toxicology.

[280]  F. Martinez,et al.  Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. , 1997, American journal of respiratory and critical care medicine.

[281]  J. Barberà,et al.  Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. , 1997, The European respiratory journal.

[282]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[283]  J. Schwartz,et al.  Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. , 1997, The European respiratory journal.

[284]  J. Bousquet,et al.  Corticosteroid reversibility in COPD is related to features of asthma. , 1997, American journal of respiratory and critical care medicine.

[285]  D. Romberger,et al.  Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.

[286]  J. P. Davis,et al.  Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[287]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[288]  A. Morice,et al.  An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.

[289]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[290]  C. Kim,et al.  Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. , 1997, American journal of respiratory and critical care medicine.

[291]  J. Heffner,et al.  Outcomes of advance directive education of pulmonary rehabilitation patients. , 1997, American journal of respiratory and critical care medicine.

[292]  P. Barnes,et al.  Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. , 1997, American journal of respiratory and critical care medicine.

[293]  D. O’Donnell,et al.  Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. , 1997, American journal of respiratory and critical care medicine.

[294]  A. Buist.  Risk factors for COPD , 1996 .

[295]  Alan D. Lopez,et al.  Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.

[296]  G. Patterson,et al.  Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[297]  Gordon H Guyatt,et al.  Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease , 1996, The Lancet.

[298]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[299]  D. Wood,et al.  Economic aspects of lung volume reduction surgery. , 1996, Chest.

[300]  W. MacNee,et al.  Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.

[301]  Romain A. Pauwels.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[302]  R. Chapela,et al.  Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. , 1996, American journal of respiratory and critical care medicine.

[303]  J. Crowley,et al.  Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.

[304]  B. Fleury,et al.  The cost of treating COPD patients with long-term oxygen therapy in a French population. , 1996, Chest.

[305]  E. Wouters,et al.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.

[306]  W. Bailey,et al.  Smoking cessation: Information for specialists , 1996 .

[307]  M. Decramer,et al.  Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[308]  D. Dusser,et al.  Environmental ImPatt on the Airways: From Injury to Repair , 1996 .

[309]  D. Postma,et al.  Effects of long-term treatment with corticosteroids in COPD. , 1996, Chest.

[310]  B. Celli.  Current thoughts regarding treatment of chronic obstructive pulmonary disease. , 1996, The Medical clinics of North America.

[311]  C. van Weel,et al.  Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? , 1996, The British journal of general practice : the journal of the Royal College of General Practitioners.

[312]  D. Sachs,et al.  Individualizing medical treatment for tobacco dependence. , 1996, The European respiratory journal.

[313]  M. Belman,et al.  Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[314]  D. Maldonado,et al.  Woodsmoke exposure and risk for obstructive airways disease among women. , 1996, Chest.

[315]  P. Macklem,et al.  Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[316]  J. Barberà,et al.  Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease , 1996, The Lancet.

[317]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[318]  R. Rogers,et al.  Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.

[319]  R. Cydulka,et al.  Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease. , 1996, Annals of emergency medicine.

[320]  J. Bousquet,et al.  Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. , 1996, Respiratory medicine.

[321]  Calverley Pm.  Neuropsychological deficits in chronic obstructive pulmonary disease. , 1996 .

[322]  E. Bleecker,et al.  Results of a multicenter study of nebulized inhalant bronchodilator solutions. , 1996, The American journal of medicine.

[323]  M. Tsukino,et al.  Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease. , 1996, Thorax.

[324]  W. Knaus,et al.  Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 1995 .

[325]  L. Fabbri,et al.  Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.

[326]  R. Goldstein,et al.  Home Mechanical Ventilation: Demographics and User Perspectives , 1995 .

[327]  G. Raghu,et al.  The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. , 1995, Chest.

[328]  D. O’Donnell,et al.  The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. , 1995, American journal of respiratory and critical care medicine.

[329]  R. Mellins,et al.  Physician‐patient partnership in managing chronic illness , 1995, Academic medicine : journal of the Association of American Medical Colleges.

[330]  M. Cosio,et al.  Alveolar inflammation and its relation to emphysema in smokers. , 1995, American journal of respiratory and critical care medicine.

[331]  J. Deslauriers,et al.  Indications for surgery and patient work-up for bullectomy. , 1995, Chest surgery clinics of North America.

[332]  S. V. Von Essen,et al.  Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge. , 1995, Chest.

[333]  M. Svartengren,et al.  Repeatability of airway deposition and tracheobronchial clearance rate over three days in chronic bronchitis. , 1995, The European respiratory journal.

[334]  L. Fabbri,et al.  Effect of smoking cessation on airway inflammation in chronic bronchitis. , 1995, American journal of respiratory and critical care medicine.

[335]  J. Ruiz,et al.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.

[336]  M. Sears,et al.  Exacerbations of asthma without sputum eosinophilia. , 1995, Thorax.

[337]  W. Bailey,et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.

[338]  M. Wysocki,et al.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. , 1995, The New England journal of medicine.

[339]  B. Celli,et al.  Long-term oxygen therapy. , 1995, The New England journal of medicine.

[340]  B. Celli.  Pulmonary rehabilitation in patients with COPD. , 1995, American journal of respiratory and critical care medicine.

[341]  I. Tager,et al.  Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. , 1995, American journal of respiratory and critical care medicine.

[342]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[343]  K. Shirato,et al.  IL‐5, IL‐8 and GM‐CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[344]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[345]  D. Postma,et al.  Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. , 1995, Thorax.

[346]  P. Moayyedi,et al.  Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. , 1995, Thorax.

[347]  P. Jones,et al.  Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. , 1995, American journal of respiratory and critical care medicine.

[348]  C. Ulrik.  Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. , 1995, Thorax.

[349]  S. Robertson.  Maternal Smoking During Pregnancy , 1995 .

[350]  Tammy O. Tengs,et al.  Five-hundred life-saving interventions and their cost-effectiveness. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[351]  A. Ries,et al.  Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995, Annals of Internal Medicine.

[352]  N. Hill,et al.  Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. , 1995, American journal of respiratory and critical care medicine.

[353]  M. Stewart.  Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[354]  M. Cazzola,et al.  Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study. , 1995, Respiratory medicine.

[355]  G. Guyatt,et al.  Randomized Controlled Trial of Respiratory Rehabilitation , 1995 .

[356]  E. Vittinghoff,et al.  Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.

[357]  K. Shirato,et al.  Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. , 1995, American journal of respiratory and critical care medicine.

[358]  R. Pistelli,et al.  Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.

[359]  A. Esteban,et al.  A COMPARISON OF FOUR METHODS OF WEANING PATIENTS FROM MECHANICAL VENTILATION , 1995 .

[360]  K. Nishimura,et al.  Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. , 1995, Chest.

[361]  G. Guyatt,et al.  Randomised controlled trial of respiratory rehabilitation , 1994, The Lancet.

[362]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[363]  M. Fiore,et al.  The Effectiveness of the Nicotine Patch for Smoking Cessation , 1994 .

[364]  U. Ackermann-Liebrich,et al.  Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.

[365]  E. Wouters,et al.  Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. , 1994, The European respiratory journal.

[366]  L. Brochard,et al.  Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. , 1994, American journal of respiratory and critical care medicine.

[367]  K. Nichol,et al.  The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.

[368]  J. Muir,et al.  Home treatment for chronic respiratory insufficiency: the situation in Europe in 1992. The European Working Group on Home Treatment for Chronic Respiratory Insufficiency. , 1994, The European respiratory journal.

[369]  W. MacNee,et al.  Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. , 1994, American journal of respiratory and critical care medicine.

[370]  T. Petty,et al.  Further recommendations for prescribing, reimbursement, technology development, and research in long-term oxygen therapy. Summary of the Fourth Oxygen Consensus Conference, Washington, D.C., October 15-16, 1993. , 1994, American journal of respiratory and critical care medicine.

[371]  M. Døssing,et al.  Risk factors for chronic obstructive lung disease in Saudi Arabia. , 1994, Respiratory medicine.

[372]  T. Evald,et al.  Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. , 1994, Respiratory medicine.

[373]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[374]  C. van Weel,et al.  Consultation rates and incidence of intercurrent morbidity among patients with chronic disease in general practice. , 1994, The British journal of general practice : the journal of the Royal College of General Practitioners.

[375]  G. Sarosi,et al.  Respiratory Infections: A Scientific Basis for Management , 1994 .

[376]  J. Schouten,et al.  Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. , 1994, The European respiratory journal.

[377]  T. Lukens,et al.  Physician estimation of FEV1 in acute exacerbation of COPD. , 1994, Chest.

[378]  B. Winkelmann,et al.  Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease. , 1994, Chest.

[379]  R. Sharrar,et al.  Passive smoking in obstructive respiratory disease in an industrialized urban population. , 1994, Environmental research.

[380]  T. Meyer,et al.  Noninvasive Positive Pressure Ventilation To Treat Respiratory Failure , 1994, Annals of Internal Medicine.

[381]  K. Chon,et al.  Ventilatory load characteristics during ventilatory muscle training. , 1994, American journal of respiratory and critical care medicine.

[382]  W. Hall,et al.  Meta-analytic review of the efficacy of smoking cessation interventions. , 1994, Drug and alcohol review.

[383]  S. Holgate,et al.  The relationship between pneumonia in early childhood and impaired lung function in late adult life. , 1994, American journal of respiratory and critical care medicine.

[384]  L. Fabbri,et al.  Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. , 1994, American journal of respiratory and critical care medicine.

[385]  X. Xu,et al.  Gender difference in smoking effects on adult pulmonary function. , 1994, The European respiratory journal.

[386]  A. Fishman.  Pulmonary rehabilitation research. , 1994, American journal of respiratory and critical care medicine.

[387]  A. Buist,et al.  Uses and limitations of mortality and health care utilization statistics in asthma research. , 1994, American journal of respiratory and critical care medicine.

[388]  D. Postma,et al.  Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. , 1994, The European respiratory journal.

[389]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[390]  J. Bousquet,et al.  Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. , 1993, The Journal of allergy and clinical immunology.

[391]  Chuan Yi Tang,et al.  A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem , 1993, Inf. Process. Lett..

[392]  K. Chapman,et al.  Physician perceptions and management of COPD. , 1993, Chest.

[393]  J. Wedzicha,et al.  Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease , 1993, The Lancet.

[394]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[395]  F. Martinez,et al.  Supported arm exercise vs unsupported arm exercise in the rehabilitation of patients with severe chronic airflow obstruction. , 1993, Chest.

[396]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[397]  M. Hetzel,et al.  Value of pulse oximetry in screening for long-term oxygen therapy requirement. , 1993, The European respiratory journal.

[398]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[399]  A. Thomson,et al.  Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. , 1993, Thorax.

[400]  J. Macfarlane,et al.  Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community , 1993, The Lancet.

[401]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[402]  J. Steiner,et al.  Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? , 1993, The American journal of medicine.

[403]  L. Fabbri,et al.  Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. , 1993, The American review of respiratory disease.

[404]  Shun-zhang Yu,et al.  Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai. , 1992, The Science of the total environment.

[405]  P. Macklem,et al.  Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease , 1992, The Lancet.

[406]  M. S. Singh,et al.  Development of a shuttle walking test of disability in patients with chronic airways obstruction. , 1992, Thorax.

[407]  J. Costantino,et al.  Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. , 1992, The American review of respiratory disease.

[408]  A. Miller,et al.  Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.

[409]  D. Postma,et al.  European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. , 1992, The European respiratory journal.

[410]  M. Lara,et al.  Guidelines For The Diagnosis And Management Of Asthma , 1992, The Journal of the American Board of Family Medicine.

[411]  T. Murphy,et al.  Bacterial infection in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[412]  M. Decramer,et al.  Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. , 1992, The American review of respiratory disease.

[413]  B. O'driscoll,et al.  A long-term prospective assessment of home nebulizer treatment. , 1992, Respiratory medicine.

[414]  T. Krone,et al.  Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness , 1992, The Lancet.

[415]  A. Woodcock,et al.  Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. , 1992, The European respiratory journal.

[416]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[417]  J. Barberà,et al.  Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[418]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[419]  A. Woolcock,et al.  Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. , 1992, The American review of respiratory disease.

[420]  H. Gong.  Air travel and oxygen therapy in cardiopulmonary patients. , 1992, Chest.

[421]  G H Guyatt,et al.  Respiratory muscle training in chronic airflow limitation: a meta-analysis. , 1992, The American review of respiratory disease.

[422]  G. Snider.  Animal Models of Chronic Airways Injury , 1992 .

[423]  B. Berg,et al.  Oxygen supplementation during air travel in patients with chronic obstructive lung disease. , 1992, Chest.

[424]  P. Diaz,et al.  Emphysema-like Pulmonary Disease Associated with Human Immunodeficiency Virus Infection , 1992, Annals of Internal Medicine.

[425]  A. Gulsvik,et al.  Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. , 1991, Thorax.

[426]  L. Cinotti,et al.  Changes in the distribution of ventilation and perfusion associated with separation from mechanical ventilation in patients with obstructive pulmonary disease. , 1991, Anesthesiology.

[427]  A. Robertson,et al.  Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse. , 1991, The European respiratory journal.

[428]  K. Murphy,et al.  The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. , 1991, The American review of respiratory disease.

[429]  K. Godfrey,et al.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. , 1991, BMJ.

[430]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[431]  N. Eiser,et al.  Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. , 1991, The European respiratory journal.

[432]  D Behera,et al.  Respiratory symptoms in Indian women using domestic cooking fuels. , 1991, Chest.

[433]  A I Mushlin,et al.  The necessary length of hospital stay for chronic pulmonary disease. , 1991, JAMA.

[434]  Y. Scherer,et al.  Can a Pulmonary Health Teaching Program Alter Patients’ Ability to Cope with COPD? , 1991, Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses.

[435]  D. Postma,et al.  Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. , 1991, Thorax.

[436]  C. van Weel,et al.  Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. , 1991, Thorax.

[437]  A. Tattersfield,et al.  Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. , 1991, The European respiratory journal.

[438]  T. Lukens,et al.  Spirometric criteria for hospital admission of patients with acute exacerbation of COPD. , 1991, Chest.

[439]  J. Ansquer,et al.  Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease. , 1991, The European respiratory journal.

[440]  R. Dittus,et al.  Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. , 1991, Annals of internal medicine.

[441]  J. Fagon,et al.  Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. , 1990, The American review of respiratory disease.

[442]  M. Teghtsoonian,et al.  Distinguishable types of dyspnea in patients with shortness of breath. , 1990, The American review of respiratory disease.

[443]  Husten Cg,et al.  How to help your patients stop smoking. , 1990 .

[444]  B. Lipworth,et al.  Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Protection by conventional doses of spironolactone but not triamterene. , 1990, Chest.

[445]  M. Lebowitz,et al.  Epidemiology of chronic obstructive pulmonary disease. , 1990, Clinics in chest medicine.

[446]  M. Wakefield,et al.  “Sick of smoking'' , 1990 .

[447]  P. Buckley,et al.  The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. , 1990, The American review of respiratory disease.

[448]  A. Connors,et al.  Theophylline concentrations in patients with acute exacerbation of COPD. , 1990, The American journal of emergency medicine.

[449]  M. Wakefield,et al.  “Sick of Smoking”: evaluation of a targeted minimal smoking cessation intervention in general practice , 1990, The Medical journal of Australia.

[450]  A. Musk,et al.  Upper-limb and lower-limb exercise training in patients with chronic airflow obstruction. , 1990, Chest.

[451]  J. Theodore,et al.  Lung transplantation comes of age. , 1990, The New England journal of medicine.

[452]  George,et al.  Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. , 1990, The Journal of clinical investigation.

[453]  P. Schnohr,et al.  Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. , 1990, The American review of respiratory disease.

[454]  J. Heinig,et al.  A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. , 1989, The European respiratory journal.

[455]  A. Cutillo,et al.  Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[456]  J. Roca,et al.  Ventilation-perfusion mismatching in chronic obstructive pulmonary disease during ventilator weaning. , 1989, The American review of respiratory disease.

[457]  M. Dunst.  Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[458]  P. Paré,et al.  The changes in airways structure associated with reduced forced expiratory volume in one second. , 1989, The European respiratory journal.

[459]  M. Feinleib,et al.  Trends in COPD morbidity and mortality in the United States. , 1989, The American review of respiratory disease.

[460]  M. Becklake.  Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[461]  T. Thom.  International comparisons in COPD mortality. , 1989, The American review of respiratory disease.

[462]  M. Aubier,et al.  A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. , 1989, The New England journal of medicine.

[463]  C. Shim.  Response to bronchodilators. , 1989, Clinics in chest medicine.

[464]  Hansen Je.  Arterial blood gases. , 1989, Clinics in chest medicine.

[465]  G. Baum.  Textbook of Pulmonary Diseases , 1989 .

[466]  T. Petty,et al.  Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. , 1989, The American review of respiratory disease.

[467]  A. Connors,et al.  Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease. , 1989, Annals of emergency medicine.

[468]  E. Daviskas,et al.  Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. , 1989, Thorax.

[469]  H. Chrystyn,et al.  Dose response relation to oral theophylline in severe chronic obstructive airways disease. , 1988, BMJ.

[470]  W. MacNee,et al.  Pulmonary hypertension and right ventricular function in patients with COPD. , 1988, Chest.

[471]  S. V. Von Essen,et al.  Mechanisms of neutrophil recruitment to the lung by grain dust exposure. , 1988, The American review of respiratory disease.

[472]  J. Britton,et al.  High-dose inhaled albuterol in severe chronic airflow limitation. , 1988, The American review of respiratory disease.

[473]  F. Speizer,et al.  The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. , 1988, The American review of respiratory disease.

[474]  M. Aubier.  Pharmacotherapy of respiratory muscles. , 1988, Clinics in chest medicine.

[475]  J. Moxham.  Aminophylline and the respiratory muscles: an alternative view. , 1988, Clinics in chest medicine.

[476]  J. Montserrat,et al.  Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. , 1988, The European respiratory journal.

[477]  R N Battista,et al.  Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. , 1988, JAMA.

[478]  S. Spiro,et al.  The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. , 1988, The American review of respiratory disease.

[479]  John F. Murray,et al.  Textbook of Respiratory Medicine , 1988 .

[480]  J. B. Rasmussen,et al.  Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. , 1988, The European respiratory journal.

[481]  M. Ardawi,et al.  Effects of sheesha and cigarette smoking on pulmonary function of Saudi males and females. , 1988, Tropical and geographical medicine.

[482]  G. Gibson,et al.  Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. , 1988, Thorax.

[483]  R. W. Hawkins,et al.  Upper Extremity Exercise Training in Chronic Obstructive Pulmonary Disease , 1988 .

[484]  D. Postma,et al.  Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? , 1988, The European respiratory journal.

[485]  J. Samet,et al.  Health effects and sources of indoor air pollution. Part I. , 1987, The American review of respiratory disease.

[486]  G. Guyatt,et al.  A controlled trial of ambroxol in chronic bronchitis. , 1987, Chest.

[487]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[488]  C. Aranda,et al.  Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. , 1987, Chest.

[489]  J. Moxham,et al.  Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. , 1987, Chest.

[490]  N. Anthonisen,et al.  Airways obstruction and the risk for lung cancer. , 1987, Annals of internal medicine.

[491]  P. Holt.  Immune and inflammatory function in cigarette smokers. , 1987, Thorax.

[492]  A. Woolcock,et al.  Rate of decline of lung function in subjects with asthma. , 1987, European journal of respiratory diseases.

[493]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[494]  B. Celli.  Respiratory muscle function. , 1986, Clinics in chest medicine.

[495]  A. Cross,et al.  Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. , 1986, The New England journal of medicine.

[496]  B. Make,et al.  Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. , 1986, The New England journal of medicine.

[497]  Anthonisen Nr,et al.  Bronchodilator response in chronic obstructive pulmonary disease. , 1986 .

[498]  T. Beaty,et al.  Genetic-environmental interactions in chronic airways obstruction. , 1986, International journal of epidemiology.

[499]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[500]  J. Hogg,et al.  Reassessment of inflammation of airways in chronic bronchitis. , 1985, British medical journal.

[501]  G. Turino,et al.  Cigarette smoke impairs elastin resynthesis in lungs of hamsters with elastase-induced emphysema. , 1985, The American review of respiratory disease.

[502]  D. Postma,et al.  Severe chronic airflow obstruction: can corticosteroids slow down progression? , 1985, European journal of respiratory diseases.

[503]  P. Wilson.  American Association of Cardiovascular and Pulmonary Rehabilitation , 1985 .

[504]  N. Burki.  Arterial blood gas measurement. , 1985, Chest.

[505]  A Rossi,et al.  Respiratory mechanics in mechanically ventilated patients with respiratory failure. , 1985, Journal of applied physiology.

[506]  D. Taylor,et al.  The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. , 1985, The American review of respiratory disease.

[507]  A Rossi,et al.  Measurement of static compliance of the total respiratory system in patients with acute respiratory failure during mechanical ventilation. The effect of intrinsic positive end-expiratory pressure. , 1985, The American review of respiratory disease.

[508]  E. Weitzenblum,et al.  Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.

[509]  M. H. Williams,et al.  Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease. , 1985, The American journal of medicine.

[510]  E. Leslie Chusid,et al.  PULMONARY FUNCTION TESTING GUIDELINES AND CONTROVERSIES , 1984 .

[511]  M. Aubier,et al.  Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. , 1984, The New England journal of medicine.

[512]  M. Pandey,et al.  Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal. , 1984, Thorax.

[513]  M. Pandey.  Prevalence of chronic bronchitis in a rural community of the Hill Region of Nepal. , 1984, Thorax.

[514]  P. Hugh-Jones,et al.  Long term changes in lung function after surgical treatment of bullous emphysema in smokers and ex-smokers. , 1984, Thorax.

[515]  M. H. Williams,et al.  Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease. , 1983, The American journal of medicine.

[516]  T. K. Hunt,et al.  Oxygen tension regulates the expression of angiogenesis factor by macrophages. , 1983, Science.

[517]  G. Snider,et al.  Functional alpha 1-protease inhibitor in the lower respiratory tract of cigarette smokers is not decreased. , 1983, Science.

[518]  F. Speizer,et al.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.

[519]  G. Boman,et al.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. , 1983, European journal of respiratory diseases.

[520]  H. Kagan,et al.  Cigarette smoke blocks cross-linking of elastin in vitro. , 1983, The American review of respiratory disease.

[521]  A. Cohen,et al.  Reduction of the elastase inhibitory capacity of alpha 1-antitrypsin by peroxides in cigarette smoke: an analysis of brands and filters. , 1982, The American review of respiratory disease.

[522]  J. Hoidal,et al.  Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[523]  A. Woodcock,et al.  Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. , 1981, The New England journal of medicine.

[524]  M. Pathy,et al.  Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis. , 1981, Thorax.

[525]  R. Mecham,et al.  Chemotactic activity of elastin-derived peptides. , 1980, The Journal of clinical investigation.

[526]  P. Vacek,et al.  Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease. , 1980, Journal of rehabilitation.

[527]  B. Cohen,et al.  Is ABH nonsecretor status a risk factor for obstructive lung disease? , 1980, American journal of epidemiology.

[528]  D. Flenley,et al.  RESPIRATORY FAILURE REVISITED: ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS BETWEEN 1961-68 AND 1970-76 , 1980, The Lancet.

[529]  R. Kanner,et al.  Effect of Viral Infections on Pulmonary Function in Patients with Chronic Obstructive Pulmonary Diseases , 1980, The Journal of infectious diseases.

[530]  I. D'cruz,et al.  Cardiac failure and infarction ECG pattern in a chronic alcoholic. , 1980, Archives of internal medicine.

[531]  C. Vassallo,et al.  Influence of starvation on enzyme-induced emphysema. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[532]  R. Crystal,et al.  Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. , 1979, Science.

[533]  J. Lellouch,et al.  Twelve years spirometric changes among Paris area workers. , 1979, International journal of epidemiology.

[534]  J Dosman,et al.  The relations between structural changes in small airways and pulmonary-function tests. , 1978, The New England journal of medicine.

[535]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[536]  S. P. Gupta,et al.  Physical rehabilitation for the chronic bronchitic: results of a controlled trial of exercises in the home. , 1977, Thorax.

[537]  M. Lebowitz,et al.  Quantitative relationships between cigarette smoking and chronic productive cough. , 1977, International journal of epidemiology.

[538]  G. Snider,et al.  Irreversible bronchial goblet cell metaplasia in hamsters with elastase-induced panacinar emphysema. , 1977, The Journal of clinical investigation.

[539]  M. Lebowitz,et al.  Quantitative relationships between cigarette smoking and ventilatory function. , 1977, The American review of respiratory disease.

[540]  W. Holland,et al.  Influence of passive smoking and parental phlegm on pneumonia and bronchitis in early childhood. , 1974, Lancet.

[541]  D. Niewoehner,et al.  Pathologic changes in the peripheral airways of young cigarette smokers. , 1974, The New England journal of medicine.

[542]  W. Thurlbeck,et al.  The number and dimensions of small airways in emphysematous lungs. , 1972, The American journal of pathology.

[543]  E. C. Hammond,et al.  Relation of smoking and age to emphysema. Whole-lung section study. , 1972, The New England journal of medicine.

[544]  D. Smith,et al.  Five-year winter chemoprophylaxis for chronic bronchitis , 1969, British medical journal.

[545]  R. Cherniack,et al.  Management of chronic obstructive pulmonary disease. , 1969, The New England journal of medicine.

[546]  J. Howell,et al.  Relation between Airways Obstruction and CO2 Tension in Chronic Obstructive Airways Disease , 1968, British medical journal.

[547]  J. Hogg,et al.  Site and nature of airway obstruction in chronic obstructive lung disease. , 1968, The New England journal of medicine.

[548]  A. Renzetti,et al.  The Veterans Administration cooperative study of pulmonary function. 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. , 1966, Aspen Emphysema Conference.

[549]  W. Barclay,et al.  CHRONIC OBSTRUCTIVE LUNG DISEASE. II. RELATIONSHIP OF CLINICAL AND PHYSIOLOGIC FINDINGS TO THE SEVERITY OF AIRWAYS OBSTRUCTION. , 1965, The American review of respiratory disease.

[550]  E. Campbell,et al.  Forced Expiratory Time: A Simple Test for Airways Obstruction , 1964, British medical journal.

[551]  L. Reid.  Measurement of the Bronchial Mucous Gland Layer: A Diagnostic Yardstick in Chronic Bronchitis * , 1960, Thorax.

[552]  C. Spicer,et al.  Chemotherapy in Chronic Bronchitis , 1960 .

[553]  J. Gough,et al.  The Centrilobular Form of Hypertrophic Emphysema and its Relation to Chronic Bronchitis , 1957, Thorax.

[554]  L. Stead,et al.  Physician advice for smoking cessation. , 2004, The Cochrane database of systematic reviews.

[555]  S. Spencer,et al.  Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study , 2003, Thorax.

[556]  A. Bentur,et al.  Terminology and definitions , 2003 .

[557]  A. Mahayiddin,et al.  COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. , 2003, Respirology.

[558]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[559]  December,et al.  International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure. , 2001 .

[560]  B. Smith,et al.  Long-acting beta2-agonists for chronic obstructive pulmonary disease. , 2000, The Cochrane database of systematic reviews.

[561]  Sarah E. Duffy,et al.  Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. , 1999, The Journal of thoracic and cardiovascular surgery.

[562]  A. Laupacis,et al.  Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. , 1999, Chest.

[563]  N. Ambrosino,et al.  Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. , 1999, The European respiratory journal.

[564]  W. MacNee,et al.  Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. , 1999, Inhalation toxicology.

[565]  E. Weitzenblum,et al.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[566]  R. Zuwallack,et al.  Pulmonary rehabilitation - 1999 , 1999 .

[567]  M. Tsukino,et al.  The effect of high-dose inhaled beclomethasone dipropionate in patients with stable COPD. , 1999, Chest.

[568]  Steven Piantadosi,et al.  Rationale and design of the national emphysema treatment trial: A prospective randomized trial of lung volume reduction surgery , 1999 .

[569]  D. Postma,et al.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. , 1999, The New England journal of medicine.

[570]  J Zieliński,et al.  Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. , 1998, Chest.

[571]  E. Wouters,et al.  Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .

[572]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report--1998. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[573]  M. Koopmanschap,et al.  Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. , 1998 .

[574]  C. Bolliger,et al.  Functional evaluation of the lung resection candidate. , 1998, The European respiratory journal.

[575]  G. Bonsel,et al.  Technology Assessment of the Dutch Lung Transplantation Program , 1998, International Journal of Technology Assessment in Health Care.

[576]  A. Buist,et al.  Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group. , 1997, Chest.

[577]  S. Weingarten,et al.  Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. , 1997, Chest.

[578]  U Ackermann-Liebrich,et al.  Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. , 1997, American journal of respiratory and critical care medicine.

[579]  Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. , 1997, Bulletin of the World Health Organization.

[580]  P. Honeyman,et al.  Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation. , 1996, Journal of cardiopulmonary rehabilitation.

[581]  H. Folgering,et al.  Nocturnal saturation improves by target-flow inspiratory muscle training in patients with COPD. , 1996, American journal of respiratory and critical care medicine.

[582]  L. Allegra,et al.  Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial. , 1996, Respiration; international review of thoracic diseases.

[583]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[584]  J. Murray,et al.  The Global Burden of Disease , 1996 .

[585]  C. Weel.  Chronic diseases in general practice: the longitudinal dimension , 1996 .

[586]  J. Cooper,et al.  Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. , 1995, The Journal of thoracic and cardiovascular surgery.

[587]  P. Calverley.  Symptomatic Bronchodilator Treatment , 1995 .

[588]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[589]  H. Sostman,et al.  Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease. Chest radiography versus high resolution computed tomography. , 1995, American journal of respiratory and critical care medicine.

[590]  N. Pride,et al.  Development of Impaired Lung Function: Natural History and Risk Factors , 1995 .

[591]  D. Strachan.  Epidemiology: A British Perspective , 1995 .

[592]  P. Barnes.  Bronchodilators: Basic Pharmacology , 1995 .

[593]  D. Harrison,et al.  Vicious Circles , 1995 .

[594]  Mathews Tj,et al.  Annual summary of births marriages divorces and deaths: United States 1994. , 1995 .

[595]  A. Buist,et al.  In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial , 1994 .

[596]  W. Dupont,et al.  A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. , 1994, The Journal of infectious diseases.

[597]  W. Poller,et al.  The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung disease , 1993 .

[598]  R. Kanner,et al.  The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. , 1992, The American review of respiratory disease.

[599]  H. Folgering,et al.  Target-flow inspiratory muscle training during pulmonary rehabilitation in patients with COPD. , 1991, Chest.

[600]  R. Crystal,et al.  The Lung: Scientific Foundations , 1991 .

[601]  D. Georgopoulos.  Symptoms and signs of COPD , 1991 .

[602]  R. Kaplan,et al.  Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status. , 1990, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[603]  Manley Mw,et al.  Physician-initiated smoking cessation program: the National Cancer Institute trials. , 1990 .

[604]  T. Petty.  The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. , 1990, Chest.

[605]  J. Fagon,et al.  Use of the Protected Specimen Brush Technique in 54 Mechanically Ventilated Patients , 1990 .

[606]  J. Samet.  Definitions and methodology in COPD research , 1989 .

[607]  P. Paré,et al.  Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. , 1987, The American journal of medicine.

[608]  D. Niewoehner,et al.  Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. , 1987, British journal of diseases of the chest.

[609]  J. L. Schwartz.  Review and evaluation of smoking cessation methods : the United States and Canada, 1978-1985 , 1987 .

[610]  J. Williams,et al.  Pneumococcal vaccine and patients with chronic lung disease. , 1986, Annals of internal medicine.

[611]  C. Westermann,et al.  Bullectomy for giant bullae in emphysema. , 1986, The Journal of thoracic and cardiovascular surgery.

[612]  E. Cassady,et al.  A Three-Center Study , 1979 .

[613]  F. Speizer,et al.  Epidemiology of chronic mucus hypersecretion and obstructive airways disease. , 1979, Epidemiologic reviews.

[614]  M. Horsmanheimo,et al.  Lung biology in health and disease , 1977 .

[615]  H. Poppius.  Airway obstruction in pulmonary tuberculosis. , 1968, Scandinavian journal of respiratory diseases. Supplementum.

[616]  J. Pierce,et al.  Pathogenesis of Pulmonary Emphysema , 1963 .

[617]  R. Stockley,et al.  Serum and sputum a2 macroglobulin in patients with chronic obstructive airways disease , 2022 .

[618]  D. Goodin,et al.  Interferons in relapsing remitting multiple sclerosis , 2003, The Lancet.

[619]  G. Marks,et al.  Primary care Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease , 2022 .